Holocene Advisors
RXST icon

Holocene Advisors’s RxSight RXST Stock Holding History

Holocene Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-315,250
Closed -$1.94M – 979
2026
Q1 		$1.94M Buy
315,250
+51,830
+20% +$430K ﹤0.01% 573
2025
Q4 		$2.74M Buy
+263,420
New +$2.64M 0.01% 458
2024
Q3 		– Sell
-24,497
Closed -$1.47M – 839
2024
Q2 		$1.47M Buy
+24,497
New +$1.4M 0.01% 567

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Holocene Advisors's RXST Position: Q2 2026 in Review

Holocene Advisors sold out of RxSight (RXST) in Q2 2026, closing a stake of 315,250 shares — an estimated $1.94M sold.

Holocene Advisors first reported a position in RXST in Q2 2024 and held it in 3 quarters. The position peaked at $2.74M in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Holocene Advisors reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Holocene Advisors sold 315,250 RxSight shares in Q2 2026, an estimated $1.94M.
  • Holocene Advisors first reported a position in RxSight in Q2 2024 and held it in 3 quarters.
  • Holocene Advisors's RxSight position peaked at $2.74M in Q4 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.